Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NM › GALLUP › REHOBOTH MCKINLEY CHRISTIAN HEALTH CARE SERVICES, INC.

REHOBOTH MCKINLEY CHRISTIAN HEALTH CARE SERVICES, INC.

NPI: 1720084999 · GALLUP, NM 87301 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 06/22/2005

$31.84M
Total Medicaid Paid
571,540
Total Claims
486,542
Beneficiaries
263
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGILLIS, WAYNE (CEO)
Parent OrganizationMCKINLEY CHRISTIAN HEALTH CARE SERVICES INC
NPI Enumeration Date06/22/2005

Related Entities

Other providers sharing the same authorized official: GILLIS, WAYNE

ProviderCityStateTotal Paid
REHOBOTH MCKINLEY CHRISTIAN HEALTH CARE SERVICES, INC GALLUP NM $9.87M
REHOBOTH MCKINLEY CHRISTIAN HEALTH CARE SERVICES, INC GALLUP NM $999K
REHOBOTH MCKINLEY CHRISTIAN HEALTH CARE SERVICES, INC GALLUP NM $527K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 118,366 $5.15M
2019 94,545 $4.43M
2020 74,055 $3.89M
2021 76,019 $4.09M
2022 74,281 $4.87M
2023 82,730 $5.39M
2024 51,544 $4.02M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 22,588 20,731 $5.75M
99283 Emergency department visit for the evaluation and management, moderate severity 27,883 26,259 $5.01M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 10,836 9,831 $3.43M
74177 Computed tomography, abdomen and pelvis; with contrast material 3,456 3,264 $1.36M
G0378 Hospital observation service, per hour 2,156 1,660 $859K
96361 Intravenous infusion, hydration; each additional hour 12,982 11,041 $773K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 4,681 4,427 $739K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 13,567 12,486 $727K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 5,971 4,857 $696K
96375 Therapeutic injection; each additional sequential IV push 11,170 9,420 $678K
70450 Computed tomography, head or brain; without contrast material 3,549 3,332 $665K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 11,108 9,517 $632K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 9,765 2,981 $552K
87631 4,188 4,021 $550K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 12,139 10,832 $512K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4,766 4,552 $485K
80053 Comprehensive metabolic panel 31,784 27,416 $430K
71045 Radiologic examination, chest; single view 7,522 6,877 $416K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,551 1,468 $383K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 982 950 $311K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 34,933 28,506 $274K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 3,437 3,171 $256K
71046 Radiologic examination, chest; 2 views 5,025 4,645 $247K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4,729 4,091 $220K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 7,127 5,301 $218K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 662 603 $215K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 307 295 $204K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 5,743 2,090 $177K
72125 Computed tomography, cervical spine; without contrast material 775 740 $165K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 4,358 4,213 $157K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 270 257 $156K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 3,527 3,309 $153K
71275 Computed tomographic angiography, chest, with contrast material 455 420 $146K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 4,209 3,987 $145K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4,184 3,984 $141K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,151 934 $128K
83690 12,582 11,276 $105K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1,860 1,290 $105K
73610 1,031 969 $102K
84484 8,672 6,509 $101K
73562 1,043 971 $92K
36415 Collection of venous blood by venipuncture 16,744 12,899 $90K
95811 158 152 $88K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 344 328 $86K
71260 Computed tomography, thorax, diagnostic; with contrast material 373 365 $84K
84443 Thyroid stimulating hormone (TSH) 4,904 4,660 $83K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 3,973 3,713 $80K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,089 1,040 $80K
80306 6,443 5,905 $77K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 117 112 $76K
83735 10,774 9,103 $72K
87040 5,098 3,019 $72K
83605 5,539 4,334 $70K
77067 Screening mammography, bilateral, including computer-aided detection 516 507 $69K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 528 496 $67K
59025 Fetal non-stress test 669 466 $66K
99281 Emergency department visit for the evaluation and management, self-limited or minor 980 942 $65K
87086 Culture, bacterial; quantitative colony count, urine 6,685 6,158 $60K
73630 967 889 $59K
81001 12,575 11,534 $58K
83880 2,310 2,072 $55K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 697 502 $54K
80048 Basic metabolic panel (calcium, ionized) 5,649 4,377 $53K
80061 Lipid panel 3,559 3,455 $51K
70486 301 286 $48K
J7030 Infusion, normal saline solution , 1000 cc 13,752 10,802 $47K
83036 Hemoglobin; glycosylated (A1C) 4,867 4,715 $47K
76705 Ultrasound, abdominal, real time with image documentation; limited 492 468 $47K
73030 500 457 $44K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2,114 2,048 $43K
88305 Level IV - Surgical pathology, gross and microscopic examination 976 820 $43K
82077 1,928 1,726 $41K
73130 664 612 $38K
96376 2,478 1,781 $37K
82652 834 818 $37K
81025 4,266 4,015 $36K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,782 1,302 $35K
85007 6,959 6,002 $32K
82948 7,655 4,149 $31K
J2785 Injection, regadenoson, 0.1 mg 227 218 $31K
84703 3,001 2,817 $29K
85610 5,159 4,499 $27K
73110 475 441 $27K
96367 744 619 $27K
85027 3,749 3,342 $27K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 793 775 $25K
97161 637 614 $24K
97162 492 470 $23K
83655 1,708 1,663 $23K
73221 95 87 $23K
29125 214 211 $23K
97010 1,657 708 $22K
74018 394 381 $22K
71250 126 122 $21K
85379 1,938 1,783 $21K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 34 33 $21K
72100 284 275 $20K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 125 118 $20K
87430 1,380 1,306 $18K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 1,077 1,051 $18K
G0379 Direct admission of patient for hospital observation care 108 100 $18K
86900 1,627 1,472 $17K
87186 1,614 1,510 $16K
J3490 Unclassified drugs 3,365 2,068 $16K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 694 675 $16K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 163 159 $15K
74021 183 171 $15K
87081 1,901 1,792 $15K
70551 Magnetic resonance imaging, brain; without contrast material 73 72 $15K
82140 1,026 910 $14K
86592 2,152 2,074 $14K
87340 1,196 1,165 $14K
87077 1,754 1,627 $13K
73564 111 108 $13K
87070 1,289 1,189 $13K
86850 1,471 1,360 $13K
86769 452 437 $13K
J0696 Injection, ceftriaxone sodium, per 250 mg 3,307 2,530 $12K
82803 600 544 $12K
81003 5,019 4,641 $12K
84439 1,132 1,080 $12K
86803 758 737 $11K
97032 873 413 $11K
85730 2,412 2,195 $10K
86140 1,712 1,478 $10K
82550 1,374 1,259 $10K
76801 98 97 $9K
77080 90 86 $8K
J7120 Ringers lactate infusion, up to 1000 cc 2,788 2,409 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg 8,686 7,594 $7K
84145 352 318 $7K
76700 Ultrasound, abdominal, real time with image documentation; complete 65 65 $7K
94060 67 66 $7K
97035 237 133 $7K
84702 399 322 $7K
87210 1,016 970 $7K
86756 431 408 $6K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 1,942 1,785 $6K
J2270 Injection, morphine sulfate, up to 10 mg 3,854 2,995 $6K
86901 1,627 1,472 $6K
86762 434 420 $6K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 14 12 $6K
90715 557 542 $6K
73140 92 86 $6K
99292 34 33 $5K
80329 615 446 $5K
76000 63 58 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg 5,412 4,912 $5K
84100 1,028 825 $5K
J7050 Infusion, normal saline solution, 250 cc 2,665 2,075 $5K
80076 419 365 $5K
J2704 Injection, propofol, 10 mg 1,313 1,174 $4K
84466 343 328 $4K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 15 12 $4K
73080 71 67 $4K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 54 51 $4K
82139 246 228 $4K
A9575 Injection, gadoterate meglumine, 0.1 ml 645 615 $4K
J2560 Injection, phenobarbital sodium, up to 120 mg 177 157 $4K
87205 831 743 $4K
82728 282 261 $4K
J3010 Injection, fentanyl citrate, 0.1 mg 1,958 1,736 $4K
J0690 Injection, cefazolin sodium, 500 mg 889 745 $3K
J3411 Injection, thiamine hcl, 100 mg 1,272 1,102 $3K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 214 206 $3K
80074 60 56 $3K
82607 184 182 $3K
83540 398 374 $3K
74019 27 27 $3K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 37 36 $3K
H0049 Alcohol and/or drug screening 69 69 $3K
85651 902 781 $3K
95812 12 12 $3K
88312 28 25 $3K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 317 309 $3K
73090 42 40 $2K
12001 28 27 $2K
80143 111 100 $2K
82150 249 238 $2K
51701 30 29 $2K
80179 96 85 $2K
73502 44 39 $2K
82950 365 355 $2K
86920 16 13 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,845 1,747 $2K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 239 165 $2K
88304 80 70 $2K
71101 27 25 $2K
J3475 Injection, magnesium sulfate, per 500 mg 416 373 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,197 1,127 $2K
J2060 Injection, lorazepam, 2 mg 2,026 1,715 $2K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 483 454 $2K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 28 12 $2K
82009 357 317 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes 14 12 $2K
94726 24 24 $2K
93971 24 24 $2K
88738 295 269 $1K
J1644 Injection, heparin sodium, per 1000 units 1,339 604 $1K
96160 35 35 $1K
80069 106 83 $1K
V2632 Posterior chamber intraocular lens 89 85 $1K
51798 17 16 $872.76
87150 29 27 $868.58
82043 101 99 $849.95
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 188 185 $830.18
81015 394 370 $829.97
82105 39 37 $765.91
82951 55 55 $761.33
82570 113 110 $736.53
73590 14 14 $709.27
94729 24 24 $596.07
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 12 12 $588.82
94760 921 647 $586.05
97164 19 19 $537.03
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 638 563 $530.28
S0164 Injection, pantoprazole sodium, 40 mg 181 164 $523.73
82947 105 92 $495.50
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 30 27 $487.11
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 548 516 $457.36
J0280 Injection, aminophyllin, up to 250 mg 113 108 $363.14
82746 27 26 $361.96
84460 56 49 $357.82
J1200 Injection, diphenhydramine hcl, up to 50 mg 433 393 $352.64
J3370 Injection, vancomycin hcl, 500 mg 137 123 $340.83
J0612 Injection, calcium gluconate, not otherwise specified, 10 mg 52 50 $317.35
85018 96 94 $316.80
86787 25 25 $295.63
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 493 433 $291.59
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 29 28 $268.59
J1170 Injection, hydromorphone, up to 4 mg 148 118 $265.79
J2550 Injection, promethazine hcl, up to 50 mg 433 396 $255.37
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 58 52 $249.32
84153 12 12 $232.75
84481 13 13 $224.80
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 91 82 $200.18
J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg 26 26 $197.61
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 15 12 $190.23
83615 46 40 $181.49
J1650 Injection, enoxaparin sodium, 10 mg 80 41 $169.87
J0780 Injection, prochlorperazine, up to 10 mg 29 26 $138.84
J3480 Injection, potassium chloride, per 2 meq 14 13 $134.60
36416 262 252 $116.56
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 98 81 $109.38
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 63 63 $103.96
J0171 Injection, adrenalin, epinephrine, 0.1 mg 85 81 $92.07
J1815 Injection, insulin, per 5 units 281 158 $91.39
J2765 Injection, metoclopramide hcl, up to 10 mg 122 110 $90.38
82272 25 24 $89.35
82270 33 29 $87.56
84450 14 12 $86.82
J2919 Injection, methylprednisolone sodium succinate, 5 mg 14 14 $63.03
84550 13 12 $58.30
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 303 187 $46.86
82962 12 12 $40.51
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 137 129 $34.97
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 97 92 $27.47
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 59 55 $19.28
C9399 Unclassified drugs or biologicals 22 21 $6.87
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 180 162 $0.93
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 181 162 $0.84
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 46 40 $0.15
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 47 41 $0.15